Trends of Stem Cell-Based Clinical Trials in Gastrointestinal Tract Diseases


  • Zahra Jabbarpour Gene Therapy Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  • Mohammad H. Ghahremani Department of Pharmacology-Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  • Massoud Saidijam Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
  • Jafar Kiani Department of Molecular Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran
  • Naser Ahmadbeigi Gene Therapy Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran



Gastrointestinal disease, Stem cell, Clinical trial, Cell therapy, Mesenchymal stem cell.


Stem cells have great potential to be applied as a treatment for various types of disorders. These cells exert therapeutic effects by modulating the immune system with the capability to secrete cytokines and chemokines. Previous studies have indicated that stem cells could be used as a therapeutic agent for different complaints, such as gastrointestinal diseases. For a long time now, researchers have moved toward stem cells' clinical application in this context. With the increasing number of trials in stem cell therapy of gastrointestinal disease, it is now time to evaluate these clinical trials' status. This paper reviews clinical trials that have used stem cells for the treatment of gastrointestinal tract diseases.


Gelberg HB. Comparative anatomy, physiology, and mechanisms of disease production of the esophagus, stomach, and small intestine. Toxicologic Pathology 2014; 42(1): 54-66. DOI:

Gronthos S, et al. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. Journal of Cell Science 2003; 116(9): 1827-1835. DOI:

Zuk PA, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Engineering 2001; 7(2): 211-228. DOI:

Lee OK, et al. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004; 103(5): 1669-1675. DOI:

Fukuchi Y, et al. Human placenta‐derived cells have mesenchymal stem/progenitor cell potential. Stem Cells 2004; 22(5): 649-658. DOI:

Simonson OE, et al. In vivo effects of mesenchymal stromal cells in two patients with severe acute respiratory distress syndrome. Stem Cells Translational Medicine 2016; 5(6): 845-845. DOI:

Zhang JB, et al. Adipose‐derived mesenchymal stem cells therapy for acute kidney injury induced by ischemia‐reperfusion in a rat model. Clinical and Experimental Pharmacology and Physiology 2017; 44(12): 1232-1240. DOI:

Ruzicka J, et al. Mesenchymal stem cells preserve working memory in the 3xTg-AD mouse model of Alzheimer’s disease. International Journal of Molecular Sciences 2016; 17(2): 152. DOI:

Onda T, et al. Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia. Journal of Cerebral Blood Flow & Metabolism 2008; 28(2): 329-340. DOI:

D’addio F, et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes: a multicenter analysis. Diabetes 2014: DB_140295. DOI:

Mathiasen AB, et al. Autotransplantation of mesenchymal stromal cells from bone-marrow to heart in patients with severe stable coronary artery disease and refractory angina—final 3-year follow-up. International Journal of Cardiology 2013; 170(2): 246-251. DOI:

Kantarcıoğlu M, et al. Efficacy of autologous mesenchymal stem cell transplantation in patients with liver cirrhosis. Turk J Gastroenterol 2015; 26(3): 244-250. DOI:

Molendijk I, et al. Allogeneic bone marrow–derived mesenchymal stromal cells promote healing of refractory perianal fistulas in patients with Crohn’s disease. Gastroenterology 2015; 149(4): 918-927. e6. DOI:

Ai J, et al. Mesenchymal stromal cells induce inhibitory effects on hepatocellular carcinoma through various signaling pathways. Cancer Cell Int 2019; 19: 329. DOI:

Baksh D, Yao R, Tuan RS. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 2007; 25(6): 1384-1392. DOI:

Christ B, Brückner S, Winkler S. The therapeutic promise of mesenchymal stem cells for liver restoration. Trends in Molecular Medicine 2015; 21(11): 673-686. DOI:

Reagan MR, et al. Stem cell implants for cancer therapy: TRAIL-expressing mesenchymal stem cells target cancer cells in situ. Journal of Breast Cancer 2012; 15(3): 273-282. DOI:

Stuckey DW, Shah K. Stem cell-based therapies for cancer treatment: separating hope from hype. Nature Reviews Cancer 2014; 14(10): 683. DOI:

del Pilar Martínez-Montiel M, Gómez-Gómez GJ, Flores AI. Therapy with stem cells in inflammatory bowel disease. World journal of gastroenterology: WJG 2014; 20(5): 1211. DOI:

Hawkey CJ, Hommes DW. Is stem cell therapy ready for prime time in treatment of inflammatory bowel diseases? Gastroenterology 2017; 152(2): 389-397. e2. DOI:

Mohamadnejad M, et al. Randomized placebo‐controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis. Liver International 2013; 33(10): 1490-1496. DOI:

Suk KT, et al. Transplantation with autologous bone marrow‐derived mesenchymal stem cells for alcoholic cirrhosis: Phase 2 trial. Hepatology 2016; 64(6): 2185-2197. DOI:

Wang L, et al. A pilot study of umbilical cord‐derived mesenchymal stem cell transfusion in patients with primary biliary cirrhosis. Journal of Gastroenterology and Hepatology 2013; 28: 85-92. DOI:

Duijvestein M, et al. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study. Gut 2010; 59(12): 1662-1669. DOI:

Hu J, et al. Safety and therapeutic effect of mesenchymal stem cell infusion on moderate to severe ulcerative colitis. Experimental and Therapeutic Medicine 2016; 12(5): 2983-2989. DOI:

Panés J, et al. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial. The Lancet 2016; 388(10051): 1281-1290. DOI:

Niess H, et al. Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I/II clinical trial. BMC Cancer 2015; 15(1): 237. DOI:

Bony C, et al. Adipose mesenchymal stem cells isolated after manual or water-jet-assisted liposuction display similar properties. Frontiers in Immunology 2016; 6: 655. DOI:

Fischer UM, et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells and Development 2009; 18(5): 683-692. DOI:

Wang M, et al. Intraperitoneal injection (IP), Intravenous injection (IV) or anal injection (AI)? Best way for mesenchymal stem cells transplantation for colitis. Scientific Reports 2016; 6: 30696. DOI:




How to Cite

Zahra Jabbarpour, Mohammad H. Ghahremani, Massoud Saidijam, Jafar Kiani, & Naser Ahmadbeigi. (2021). Trends of Stem Cell-Based Clinical Trials in Gastrointestinal Tract Diseases . Journal of Analytical Oncology, 9, 56–62.